A novel compound, developed by College of Veterinary Medicine researchers, that has the potential to starve the bacteria that causes tuberculosis – the world’s second-leading infectious killer – is entering human clinical trials.
Students in the Milstein Program in Technology & Humanity spent eight weeks this summer exploring New York City and thinking deeply about the implications of technology.
A research collaboration has found an efficient way to expand the collective behavior of swarming microrobots: Mixing different sizes of the micron-scale ‘bots enables them to self-organize into diverse patterns that can be manipulated when a magnetic field is applied.
The Tree of Life Center – with 174 units, community and retail space, and a full-service health center and dental clinic – opened on Dec. 9 in Jamaica, Queens.
Hospitals have begun using “decision support tools” powered by artificial intelligence that can diagnose disease, suggest treatment or predict a surgery’s outcome.
Students were tasked with addressing one of four challenges: creating new dairy products, coming up with more efficient food manufacturing processes, lessening the problem of food waste or creating products to increase knowledge and the use of honey and other bee-pollinated products.
A small but significant metabolic difference between human and mouse lung tumor cells has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results and pointing toward new strategies for developing cancer treatments.
Forte Protein – a new Cornell startup that grows commercial animal proteins inside agricultural plants – has joined the university’s Center for Life Science Ventures business incubator.